NCT00681980已完成3 期
Study Of Valproic Acid To Treat TSP/HAM Patients In Sao Paulo, Brazil
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Neurological sacles
研究概览
简要总结
Is the valproic acid efficacy to treat TSP/HAM
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •HTLV-1; TSP/HAM fulfill criteria
排除标准
- •Age <18 years
研究组 & 干预措施
A, 2, III
Experimental
Patients with side effects to corticosteroids
干预措施: Valproic acid (Drug)
B
Experimental
patient with corticosteroids
干预措施: costicosteroids (Drug)
3
Experimental
Valproic acid and corticosteroids
干预措施: valproid acid plus corticosteroids (Drug)
结局指标
主要结局
Neurological sacles
时间窗: 24 months
次要结局
- Quality of life(2009)
研究者
Jorge Casseb
Professor
University of Sao Paulo
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Study of Efficacy and Safety of Valproic Acid in Chronic Lymphocytic Leukemia (CLL)Chronic Lymphocytic LeukemiaNCT00810680All India Institute of Medical Sciences, New Delhi10
终止
2 期
Efficacy of Valproate in Peripheral Neuropathic PainNeuralgiaNeuropathic Peripheral PainNCT00221637University Hospital, Bordeaux40
撤回
1 期
Valproic Acid in Childhood Progressive Brain TumorsPediatric Brain TumorAnaplastic AstrocytomaMedulloblastomaGlioblastomaGliomaNCT01861990Medical University of South Carolina
已完成
2 期
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDSMyelodysplastic SyndromesNCT00439673Gruppo Italiano Malattie EMatologiche dell'Adulto62
已完成
2 期
Trial of Oral Valproic Acid for Retinitis PigmentosaRetinitis PigmentosaNCT01233609Foundation Fighting Blindness90